China OTC Drug Market Report

2007

Publication Date	July 2007
Publisher	Research in China
Product Type	Report
Pages	24
ISBN Number	not applicable
Product Code	RIC00209

Price

£195.00
approximately: $364 | €247

PDF

Order above formats by FAX

Summary

By 2003, the global OTC drug market had reached 63 billion, and China's OTC drugs shared 5.7% of the global market, only behind North America, West Europe and Japan. In 2003, the sales value in China's OTC drug market achieved as high as USD 3.6 billion.

Currently, China has owned 4488 varieties of OTC drugs, including 3511 kinds of Chinese traditional patent medicine and 977 kinds of chemical drugs. The former occupies about 25% of the gross drug volume in China. Besides, Chinese traditional patent medicine shared over 40% in China's OTC drug market.

Content

1. Overview of OTC Drugs
- 1.1 Drug Classification
- 1.2 Selection standard
- 1.3 Market scale
- 1.4 China's OTC medicine varieties
2. Analysis on OTC drug market
- 2.1 Overall analysis
- 2.2 Driving forces
- 2.3 Major factors influencing enterprise competency
  - 2.3.1 Product quality and curative effect
  - 2.3.2 Prices
  - 2.3.3 Brand reputation
  - 2.3.4 Construction and maintenance of marketing channels
3. Analysis on major companies
- 3.1 Tongrentang
- 3.2 Yunnan Baiyao
- 3.3 CONBA
- 3.4 Jiangzhong Pharmaceutical